Atlas Trials

Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma

Clinical trial NCT01370135 · COMPLETED

Trial details

NCT number
NCT01370135
Sponsor
University of Luebeck
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Neovascular GlaucomaRubeosis
Start date
2008-11-01
Primary completion
2011-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.